The high degree of size heterogeneity of apo (a), the distinct protein component of
lipoprotein (a)[Lp (a)], renders the development and selection of specific antibodies directed …

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular
Mortality - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Abstract Lipoprotein (a)[Lp (a)] is a well-recognized, independent risk factor for
atherosclerotic cardiovascular disease, with elevated levels estimated to be prevalent in …

Human epidemiologic and genetic evidence using the Mendelian randomization approach
in large-scale studies now strongly supports that elevated lipoprotein (a)[Lp (a)] is a causal …

Background—Studies of the association between the plasma concentration of lipoprotein
(a)[Lp (a)] and coronary heart disease (CHD) have reported apparently conflicting findings …

Background—Elevated lipoprotein (a) levels are associated with myocardial infarction (MI)
in some but not all studies. Limitations of previous studies include lack of risk estimates for …

The importance of low-density lipoprotein (LDL) cholesterol in the development of
atherosclerosis has long been recognized, and LDL cholesterol remains the primary target …

Advances in our understanding of the ways in which the traditional cardiovascular risk
factors, including standard lipid (eg, total cholesterol, low-density lipoprotein cholesterol …

Dyslipidemia is an established cardiovascular (CV) risk factor in the general population. In
chronic kidney disease (CKD), however, epidemiologic studies (1–3) and clinical trials (4 …

Objectives: The purpose of this study was to assess the prognostic utility of lipoprotein (a)[Lp
(a)] in individuals with coronary artery disease (CAD). Background: Data regarding an …